These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2041918)

  • 1. [Mefloquine and halofantrine, new therapeutic drugs of malaria].
    Le Bras J; Ringwald P; Monsérié C; Basco LK
    Rev Med Interne; 1991; 12(1):68-74. PubMed ID: 2041918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type RI resistance to halofantrine in West Africa.
    Basco LK; Le Bras J; Gillotin C; Ringwald P; Rabenjarson E; Gimenez F; Bouchaud O; Farinotti R; Coulaud JP
    Trop Med Parasitol; 1991 Dec; 42(4):413-4. PubMed ID: 1665577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire).
    Yavo W; Bla KB; Djaman AJ; Assi SB; Basco LK; Mazabraud A; Koné M
    Afr Health Sci; 2010 Jun; 10(2):111-6. PubMed ID: 21326960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cross resistance to mefloquine and halofantrine in a case of P. falciparum malaria contracted in Sierra Leone].
    Félix R; Gay F; Lyogoubi A; Bustos MD; Diquet B; Danis M; Gentilini M
    Bull Soc Pathol Exot; 1990; 83(1):43-5. PubMed ID: 2190703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The proper use of antimalarial drugs currently available].
    Bourgeade A; Delmont J
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
    Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R
    East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halofantrine for the treatment of mefloquine chemoprophylaxis failures in Plasmodium falciparum infections.
    Shanks GD; Watt G; Edstein MD; Webster HK; Suriyamongkol V; Watanasook C; Panpunnung S; Kowinwiphat W
    Am J Trop Med Hyg; 1991 Oct; 45(4):488-91. PubMed ID: 1951857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon.
    Louis JP; Hengy C; Louis FJ; Gazin P; Jambou R; Gardon J; Fadat G; Trebucq A
    Trop Med Parasitol; 1992 Jun; 43(2):118-20. PubMed ID: 1519023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method.
    Webster HK; Boudreau EF; Pavanand K; Yongvanitchit K; Pang LW
    Am J Trop Med Hyg; 1985 Mar; 34(2):228-35. PubMed ID: 3885770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa).
    Ouédraogo JB; Dutheil Y; Tinto H; Traoré B; Zampa H; Tall F; Coulibaly SO; Guiguemdé TR
    Trop Med Int Health; 1998 May; 3(5):381-4. PubMed ID: 9623943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum.
    Ndong JM; Atteke C; Aubouy A; Bakary M; Lébibi J; Deloron P
    Trop Med Int Health; 2003 Jan; 8(1):25-9. PubMed ID: 12535246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria.
    ter Kuile FO; Dolan G; Nosten F; Edstein MD; Luxemburger C; Phaipun L; Chongsuphajaisiddhi T; Webster HK; White NJ
    Lancet; 1993 Apr; 341(8852):1044-9. PubMed ID: 8096956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of multidrug-resistant Plasmodium falciparum in Thailand: in vitro tracking.
    Wongsrichanalai C; Webster HK; Wimonwattrawatee T; Sookto P; Chuanak N; Thimasarn K; Wernsdorfer WH
    Am J Trop Med Hyg; 1992 Jul; 47(1):112-6. PubMed ID: 1636877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antimalarials. A risk-benefit analysis.
    Nosten F; Price RN
    Drug Saf; 1995 Apr; 12(4):264-73. PubMed ID: 7646825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum.
    Basco LK; Le Bras J
    Am J Trop Med Hyg; 1992 Oct; 47(4):521-7. PubMed ID: 1443351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives.
    Basco LK; Le Bras J
    Ann Trop Med Parasitol; 1994 Apr; 88(2):137-44. PubMed ID: 8067809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemotherapy of rodent malaria. XLII. Halofantrine and halofantrine resistance.
    Peters W; Robinson BL; Ellis DS
    Ann Trop Med Parasitol; 1987 Oct; 81(5):639-46. PubMed ID: 3331253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Plasmodium falciparum to four antimalarial drugs in the Central Province of Papua New Guinea.
    Hombhanje FW
    P N G Med J; 1998 Jun; 41(2):51-8. PubMed ID: 10934544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.